| #41 |
Daniel Chen |
Genentech |
3 |
| #41 |
Quinn Deveraux |
Inhibrx |
3 |
| #41 |
Jeffrey P. Harris |
University of California |
3 |
| #41 |
Eric R. Moellering |
Viridos |
3 |
| #41 |
Elai Davicioni |
Decipher Biosciences |
3 |
| #41 |
Lieven Verslegers |
Luxtera |
3 |
| #41 |
Sunil K. Srivastava |
Cisco |
3 |
| #41 |
Francisco Martinez de Velasco Cortina |
Ballogy |
3 |
| #41 |
Stephanie Moyerman |
Intel |
3 |
| #41 |
Dale L. Boger |
Scripps Research |
3 |
| #41 |
Sung-Ju Moon |
Immunomedics |
3 |
| #41 |
Kazuko Matsuda |
Medicinova |
3 |
| #41 |
Steve Howard |
Reva Medical |
3 |
| #41 |
David Forney |
Smartdrive Systems |
3 |
| #65 |
Boubacar Kante |
University of California |
2 |
| #65 |
Chengjin Zhang |
Broadcom |
2 |
| #65 |
Patrick Mercier |
University of California |
2 |
| #65 |
Nikola Alic |
Ntwine |
2 |
| #65 |
Sonia Sharma |
Immune Disease Institute |
2 |
| #65 |
Dirk Johannes Van Den Boom |
Sequenom |
2 |
| #65 |
Eric HAMPTON |
Scripps Research |
2 |
| #65 |
Yan Deng |
Qualcomm |
2 |
| #65 |
Alexander Bogdan Niculescu |
Indiana University Research And Technology |
2 |
| #65 |
Mayra YEBRA |
University of California |
2 |
| #65 |
Devin M. Swanson |
Johnson & Johnson |
2 |
| #65 |
Paolo Minero |
Qualcomm |
2 |
| #65 |
Fabrice Pierre |
Vertex Pharmaceuticals Incorporated |
2 |
| #65 |
David Sai-Ho CHU |
Avidity Biosciences |
2 |
| #65 |
Seshagiri Rao Madhavapeddy |
Frore Systems |
2 |
| #65 |
Alan Glicklich |
Arena Pharmaceuticals |
2 |
| #65 |
Roberto Spreafico |
Synthetic Genomics |
2 |
| #65 |
Yusuf Yazici |
Samumed |
2 |
| #65 |
John Rodenrys |
Leading Biosciences |
2 |
| #65 |
Lesley Henegar |
— |
2 |
| #65 |
Rajay Pandit |
Inhibrx |
2 |
| #65 |
Joseph P. Noel |
Salk Institute For Biological Studies |
2 |
| #65 |
Anjana Rao |
Children'S Medical Center |
2 |
| #65 |
Jeffery W. Kelly |
Scripps Research |
2 |
| #65 |
Hampton Sessions |
Sanford Burnham Prebys Medical Discovery Institute |
2 |
| #65 |
Shawn Griffis |
Szent |
2 |
| #65 |
Ruth T. Yu |
Salk Institute For Biological Studies |
2 |
| #65 |
H. Kirk Hammond |
University of California |
2 |
| #65 |
Abrahim Hussain |
Inhibrx |
2 |
| #65 |
Peter Newton |
K2M |
2 |
| #65 |
Richard A. Lerner |
Scripps Research |
2 |
| #65 |
Robert C. Dynes |
University of California |
2 |
| #65 |
William C. Mobley |
Neurofluidics |
2 |
| #65 |
James Beckman |
Qualcomm |
2 |
| #65 |
David Rodgers |
Scripps Research |
2 |
| #65 |
Barbora Malecova |
Avidity Biosciences |
2 |